LOW HBsAg LEVELS MAINTAINED FOLLOWING CESSATION OF THE GALNAC-siRNA, AB-729, IN CHRONIC HEPATITIS B SUBJECTS ON NUCLEOS(T)IDE ANALOGUE THERAPY

被引：0
|
作者：
Yuen, Man Fung [1 ]
Berliba, Elina [2 ]
Sukeepaisarnjaroen, Wattana [3 ]
Tangkijvanich, Pisit [4 ]
Leerapun, Apinya [5 ]
Holmes, Jacinta A. [6 ]
Gane, Edward J. [7 ]
Jucov, Alina [2 ]
Thi, Emily P. [8 ]
Sofia, Michael J. [8 ]
Sevinsky, Heather [9 ]
Eley, Timothy [9 ]
Medvedeva, Elina [9 ]
Gray, Kevin [9 ]
Antoniello, Deana [9 ]
Picchio, Gaston R. [9 ]
Sims, Karen [9 ]
Strasser, Simone I. [10 ]
机构：
[1] Univ Hong Kong, Hong Kong, Peoples R China
[2] Nicolae Testemitanu State Univ Med & Pharm Republ, Kishinev, Moldova
[3] Khon Kaen Univ, Srinagarind Hosp, Khon Kaen, Thailand
[4] Chulalongkorn Univ, Fac Med, Ctr Excellence Hepatitis & Liver Canc, Bangkok, Thailand
[5] Maharaj Nakorn Chiang Mai Hosp, Chiang Mai, Thailand
[6] St Vincents Hosp, Gastroenterol, Melbourne, Vic, Australia
[7] Univ Auckland, Auckland, New Zealand
[8] Arbutus Biopharma, Res Discovery, Warminster, PA USA
[9] Arbutus Biopharma, Clin Dev, Warminster, PA USA
[10] RPA, Liver Transplant, Sydney, NSW, Australia
来源：
HEPATOLOGY | 2021年 / 74卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LP18
引用
收藏
页码：1402A / 1403A
页数：2
相关论文
共 50 条
  • [1] SAFETY AND PHARMACODYNAMICS OF THE GALNAC-siRNA AB-729 IN SUBJECTS WITH CHRONIC HEPATITIS B INFECTION
    Yuen, Man Fung
    Berliba, Elina
    Kim, Yoon Jun
    Holmes, Jacinta A.
    Lim, Young-Suk
    Strasser, Simone I.
    Schwabe, Christian
    Jucov, Aline
    Lee, Amy C. H.
    Thi, Emily P.
    Harasym, Troy
    Pamulapati, G. R.
    Wattamwar, Paratosh
    Kunta, Jeevan
    Sofia, Michael J.
    Sevinsky, Heather
    Gray, Kevin
    Eley, Timothy
    Picchio, Gaston R.
    Sims, Karen
    Gene, Edward J.
    HEPATOLOGY, 2020, 72 : 62A - 63A
  • [2] A single dose of the GalNAc-siRNA, AB-729, results in prolonged reductions in HBsAg, HBcrAg, HBV DNA and HBV RNA in the absence of nucleos (t)ide analogue therapy in HBeAg negative subjects with chronic hepatitis B infection
    Gane, Edward
    Sevinsky, Heather
    Yuen, Man-Fung
    Anderson, Mark
    Cloherty, Gavin
    Thi, Emily P.
    Wattamwar, Tosh
    Sofia, Michael J.
    Gray, Kevin
    Antoniello, Deana
    Eley, Timothy
    Picchio, Gaston
    Sims, Karen
    JOURNAL OF HEPATOLOGY, 2021, 75 : S762 - S763
  • [3] Repeat dosing of the GalNAc-siRNA AB-729 in subjects with chronic hepatitis B results in robust and sustained HBsAg suppression
    Yuen, Man-Fung
    Berliba, Elina
    Sukeepaisarnjaroen, Wattana
    Strasser, Simone
    Tangkijvanich, Pisit
    Holmes, Jacinta
    Leerapun, Apinya
    Jucov, Alina
    Thi, Emily P.
    Wattamwar, Tosh
    Sofia, Michael J.
    Sevinsky, Heather
    Gray, Kevin
    Antoniello, Deana
    Eley, Timothy
    Picchio, Gaston
    Sims, Karen
    Gane, Edward
    JOURNAL OF HEPATOLOGY, 2021, 75 : S203 - S204
  • [4] Continued suppression of viral markers observed following discontinuation of nucleos (t)ide analogue therapy in chronic hepatitis B subjects with low hepatitis B surface antigen levels after 48 weeks of treatment with AB-729
    Yuen, Man-Fung
    Strasser, Simone
    Sukeepaisarnjaroen, Wattana
    Sharma, Varun
    Antoniello, Deana
    Medvedeva, Elina
    Thi, Emily P.
    Picchio, Gaston
    Eley, Timothy
    Sims, Karen
    JOURNAL OF HEPATOLOGY, 2022, 77 : S878 - S879
  • [5] HEPATITIS B VIRAL CONTROL MAINTAINED DURING EXTENDED FOLLOW UP OF HBEAG- CHRONIC HEPATITIS B (CHB) SUBJECTS WHO DISCONTINUED NUCLEOS(T)IDE ANALOGUE (NA) THERAPY AFTER COMPLETION OF AB-729 TREATMENT, AND IN HBEAG plus SUBJECTS STILL ON NA THERAPY
    Yuen, Man-Fung
    Holmes, Jacinta A.
    Strasser, Simone I.
    Leerapun, Apinya
    Sukeepaisarnjaroen, Wattana
    Tangkijvanich, Pisit
    Sharma, Varun
    Medvedeva, Elina
    Thi, Emily P.
    Picchio, Gaston R.
    Eley, Timothy
    Sims, Karen
    HEPATOLOGY, 2023, 77 (05) : E156 - E157
  • [6] Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
    Kim, Soon Sun
    Cheong, Jae Youn
    Cho, Sung Won
    GUT AND LIVER, 2011, 5 (03) : 278 - 287
  • [7] Adherence to nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B
    Manolakopoulos, Spilios
    Goulis, John
    Striki, Athanasia
    Deutsch, Melanie
    Perlepe, Nikoleta
    Triantos, Christos
    Papatheodoridis, George V.
    GASTROENTEROLOGY, 2015, 148 (04) : S1068 - S1068
  • [8] Letter: Safety after cessation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B infection
    Liu, Yen-Chun
    Jeng, Wen-Juei
    Chien, Rong-Nan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (07) : 731 - 732
  • [9] 48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients
    Gao, Li
    Hu, Yue
    Shi, Xiaofeng
    Li, Xin
    Zhang, Dazhi
    Ren, Hong
    ANNALS OF HEPATOLOGY, 2020, 19 (03) : 329 - 334
  • [10] HBsAg decline after interrupting nucleos(t)ide analogue therapy in HVeAg-negative chronic hepatitis B
    Siederdissen, C. Hoener zu
    Rinker, F.
    Falk, C. S.
    Filmann, N.
    Maasoumy, B.
    Deterding, K.
    Port, K.
    Mix, C.
    Herrmann, E.
    Wedemeyer, H.
    Manns, M. P.
    Kraft, A. R. M.
    Cornberg, M.
    JOURNAL OF CLINICAL VIROLOGY, 2015, 69 : 233 - 233
12345